Interpretative commenting: a tool for improving the laboratory-clinical interface.

[1]  A. Jones,et al.  Foreword , 1967, British Journal of Cancer.

[2]  B. Wolffenbuttel,et al.  Interference from heterophilic antibodies in seven current TSH assays , 2008, Annals of clinical biochemistry.

[3]  L. Liotta,et al.  National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirements. , 2008, Clinical chemistry.

[4]  S. Dovey,et al.  Testing process errors and their harms and consequences reported from family medicine practices: a study of the American Academy of Family Physicians National Research Network , 2008, Quality & Safety in Health Care.

[5]  T. Walley,et al.  Evaluating laboratory diagnostic tests , 2008, BMJ : British Medical Journal.

[6]  D. Melzer,et al.  Genetic tests for common diseases: new insights, old concerns , 2008, BMJ : British Medical Journal.

[7]  I. Barlow.  Are biochemistry interpretative comments helpful? Results of a general practitioner and nurse practitioner survey , 2008, Annals of clinical biochemistry.

[8]  S. Adelstein,et al.  Consensus guidelines on anti-beta 2 glycoprotein I testing and reporting. , 2008, Pathology.

[9]  Fred S Apple,et al.  Universal definition of myocardial infarction. , 2007, Journal of the American College of Cardiology.

[10]  Mario Plebani,et al.  Errors in a stat laboratory: types and frequencies 10 years later. , 2007, Clinical chemistry.

[11]  N. Bizzaro,et al.  Interpretative comments on autoantibody tests. , 2007, Autoimmunity reviews.

[12]  Anand Dighe,et al.  “Pre-pre” and “post-post” analytical error: high-incidence patient safety hazards involving the clinical laboratory , 2007, Clinical chemistry and laboratory medicine.

[13]  Mario Plebani,et al.  Errors in laboratory medicine and patient safety: the road ahead , 2007, Clinical chemistry and laboratory medicine.

[14]  P. Cram,et al.  The frequency of missed test results and associated treatment delays in a highly computerized health system , 2007, BMC family practice.

[15]  M. Plebani,et al.  Non-invasive assessment of chronic liver and gastric diseases. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[16]  M. Plebani.  Quality specifications: self pleasure for clinical laboratories or added value for patient management? , 2007, Clinical chemistry and laboratory medicine.

[17]  Graham R.D. Jones,et al.  Reporting units for therapeutic drug monitoring: a correctable source of potential clinical error , 2007, The Medical journal of Australia.

[18]  S. Vasikaran,et al.  The assessment of interpretation in clinical biochemistry: a personal view , 2007, Annals of clinical biochemistry.

[19]  Catherine Yoon,et al.  Missed and delayed diagnoses in the emergency department: a study of closed malpractice claims from 4 liability insurers. , 2007, Annals of emergency medicine.

[20]  C. Bieglmayer,et al.  Roche Elecsys Prolactin II assay: reactivity with macroprolactin compared with eight commercial assays for prolactin and determination of monomeric prolactin by precipitation with polyethylene glycol. , 2007, Clinical laboratory.

[21]  P. J. Howanitz,et al.  Evaluation of total serum calcium critical values. , 2009, Archives of pathology & laboratory medicine.

[22]  T. Brennan,et al.  Missed and Delayed Diagnoses in the Ambulatory Setting: A Study of Closed Malpractice Claims , 2006, Annals of Internal Medicine.

[23]  M. Laposata,et al.  Translational research involving new biomarkers of disease: a leading role for pathologists. , 2006, American journal of clinical pathology.

[24]  M. Plebani.  Errors in clinical laboratories or errors in laboratory medicine? , 2006, Clinical chemistry and laboratory medicine.

[25]  Mario Plebani,et al.  Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. , 2006, Journal of hepatology.

[26]  Mario Plebani,et al.  Laboratory network of excellence: enhancing patient safety and service effectiveness , 2006, Clinical chemistry and laboratory medicine.

[27]  J. Kay.  Technology to improve quality and accountability , 2006, Clinical chemistry and laboratory medicine.

[28]  F. Marincola,et al.  Research translation: a new frontier for clinical laboratories , 2006, Clinical chemistry and laboratory medicine.

[29]  N. Franklin,et al.  Diagnostic error in internal medicine. , 2005, Archives of internal medicine.

[30]  S. Nundy,et al.  The growth of physician medical malpractice payments: evidence from the National Practitioner Data Bank. , 2005, Health affairs.

[31]  Robert A McNutt,et al.  Missed hypothyroidism diagnosis uncovered by linking laboratory and pharmacy data. , 2005, Archives of internal medicine.

[32]  Anand S Dighe,et al.  Physician survey of a laboratory medicine interpretive service and evaluation of the influence of interpretations on laboratory test ordering. , 2004, Archives of pathology & laboratory medicine.

[33]  David W Bates,et al.  "I wish I had seen this test result earlier!": Dissatisfaction with test result management systems in primary care. , 2004, Archives of internal medicine.

[34]  M. Plebani.  What information on quality specifications should be communicated to clinicians, and how? , 2004, Clinica chimica acta; international journal of clinical chemistry.

[35]  E. Kilpatrick.  Can the addition of interpretative comments to laboratory reports influence outcome? An example involving patients taking thyroxine , 2004, Annals of clinical biochemistry.

[36]  N. Cook,et al.  Clinical Usefulness of Very High and Very Low Levels of C-Reactive Protein Across the Full Range of Framingham Risk Scores , 2004, Circulation.

[37]  R. Phillips,et al.  Learning from malpractice claims about negligent, adverse events in primary care in the United States , 2004, Quality and Safety in Health Care.

[38]  J. Beilby,et al.  Quality assessment of interpretative commenting in clinical chemistry. , 2004, Clinical chemistry.

[39]  M. Laposata.  Patient-specific narrative interpretations of complex clinical laboratory evaluations: who is competent to provide them? , 2004, Clinical chemistry.

[40]  S. Adelstein,et al.  Consensus guidelines on anti-cardiolipin antibody testing and reporting. , 2004, Pathology.

[41]  M. Plebani,et al.  Interpretative comments and reference ranges in EQA programs as a tool for improving laboratory appropriateness and effectiveness. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[42]  J. Beilby,et al.  A discussion of cases in the 2001 RCPA‐AQAP Chemical Pathology Case Report Comments Program , 2003, Pathology.

[43]  Eric Schneider,et al.  Views of practicing physicians and the public on medical errors. , 2002, The New England journal of medicine.

[44]  S. Vasikaran,et al.  Review of a pilot quality-assessment program for interpretative comments , 2002, Annals of clinical biochemistry.

[45]  P. Sipponen,et al.  Atrophic Gastritis Serum Levels of Amidated Gastrin-17 and Pepsinogen I in Atrophic Gastritis: An Observational Case-Control Study , 2002, Scandinavian journal of gastroenterology.

[46]  P. Maurette,et al.  [To err is human: building a safer health system]. , 2002, Annales francaises d'anesthesie et de reanimation.

[47]  M. Plebani,et al.  Which surrogate marker can be used to assess the effectiveness of the laboratory and its contribution to clinical outcome? , 2001, Annals of clinical biochemistry.

[48]  E. Kilpatrick,et al.  Use of computer terminals on wards to access emergency test results: a retrospective audit , 2001, BMJ : British Medical Journal.

[49]  A. Fasano,et al.  Macroamylasemia in patients with celiac disease , 2001, American Journal of Gastroenterology.

[50]  W. Marshall,et al.  Provision of interpretative comments on biochemical report forms , 2000, Annals of clinical biochemistry.

[51]  G D Schiff,et al.  Prescribing potassium despite hyperkalemia: medication errors uncovered by linking laboratory and pharmacy information systems. , 2000, The American journal of medicine.

[52]  A. Wall,et al.  Book ReviewTo Err is Human: building a safer health system Kohn L T Corrigan J M Donaldson M S Washington DC USA: Institute of Medicine/National Academy Press ISBN 0 309 06837 1 $34.95 , 2000 .

[53]  R. Cunney,et al.  Interpretative reporting and selective antimicrobial susceptibility release in non-critical microbiology results. , 2000, The Journal of antimicrobial chemotherapy.

[54]  L Sciacovelli,et al.  Reference Intervals: Are Interlaboratory Differences Appropriate? , 1999, Clinical chemistry and laboratory medicine.

[55]  G. Challand,et al.  Experience with Assessing the Quality of Comments on Clinical Biochemistry Reports , 1999, Annals of clinical biochemistry.

[56]  G. Challand.  Assessing the Quality of Comments on Reports: A Retrospective Study , 1999, Annals of clinical biochemistry.

[57]  G D Lundberg,et al.  The need for an outcomes research agenda for clinical laboratory testing. , 1998, JAMA.

[58]  B. McCarthy,et al.  Patient notification and follow-up of abnormal test results. A physician survey. , 1996, Archives of internal medicine.

[59]  G D Lundberg,et al.  Acting on significant laboratory results. , 1981, JAMA.